Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

1.09
+0.08007.92%
Post-market: 1.110.0200+1.83%19:59 EDT
Volume:538.13K
Turnover:574.16K
Market Cap:5.13M
PE:-0.05
High:1.12
Open:1.02
Low:1.01
Close:1.01
Loading ...

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

GlobeNewswire
·
28 Jan

Conduit Pharmaceuticals Inc trading halted, news pending

TIPRANKS
·
25 Jan

BRIEF-Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Reuters
·
23 Jan

Conduit Pharmaceuticals Inc - Approves 1-for-100 Reverse Stock Split

THOMSON REUTERS
·
23 Jan

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

THOMSON REUTERS
·
23 Jan

Conduit Pharmaceuticals Partners With Agility Life Sciences to Create Enhanced Formulations for Its Autoimmune Pipeline

THOMSON REUTERS
·
22 Jan

Conduit Pharmaceuticals partners with Agility Life Sciences

TIPRANKS
·
22 Jan

Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December

Benzinga
·
10 Jan

CDT Capital Management Explains Commonsense Violations With the Help of Apple (AAPL) Stock

Insider Monkey
·
09 Jan

BDSX Stock Rises After Publication of Study Data for Nodify CDT Test

Zacks
·
08 Jan

Biodesix announces publication of new Nodify CDT clinical validation study

TIPRANKS
·
07 Jan

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

GlobeNewswire
·
07 Jan

CDT Environmental Technology Reports Decline in 2024 Interim Results Amid PRC Economic Slowdown

TIPRANKS
·
27 Dec 2024

CDT Environmental Technology Reports Interim Results; Revenues ~$12.7M For Six Months Ended Jun. 30, Down 18.1% YoY, Net Income ~$1.4M, Down 21.6%

Benzinga
·
27 Dec 2024

CDT Environmental reports 1H EPS 14c vs. 22c last year

TIPRANKS
·
27 Dec 2024

CDT Environmental lowers FY24 revenue view $30.2M-$32.7M from $42.5M-$47M

TIPRANKS
·
27 Dec 2024